Safety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis
Clinical trial NCT05647096 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05647096
- Sponsor
- Santersus AG
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-05-05
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.